Parallax Volatility Advisers, L.P. Theravance Biopharma, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $4.02 Million - $6.49 Million	258,005 Added 319.14%	338,848 $5.53 Million
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $1.82 Million - $2.28 Million	80,843 New	80,843 $1.83 Million
Q1 2018 May 15, 2018	SELL	$23.37 - $29.71 $149,194 - $189,668	-6,384 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $164,834 - $227,653	6,384	6,384 $178,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.